Search

Search results

1502 results found

Adenosine A2A receptor antagonists for Parkinson’s disease: rationale, therapeutic potential and clinical experience. Drugs Aging. 2005;22:471-482.

Publication: Journal Article

Hauser, RA, and MA Schwarzchild. 2005. “Adenosine A2A Receptor Antagonists for Parkinson’s Disease: Rationale, Therapeutic Potential and Clinical Experience. Drugs Aging. 2005;22:471-482.”. Drugs Aging.

Levetiracetam for the treatment of essential tremor. Movement Disorders 2005; 20:640.

Publication: Journal Article

Sullivan, KL, RA Hauser, and TA Zesiewicz. 2005. “Levetiracetam for the Treatment of Essential Tremor. Movement Disorders 2005; 20:640.”. Movement Disorders.

Maha Ahmed joins the lab!

News: September 13, 2023

Maha is an undergraduate student at USF and used the word homeostasis when she interviewed. The start of a new promising kidney researcher!

Dr. Zietara awarded a T32 grant

News: November 01, 2024

Congrats Adrian!

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington’s disease.

Publication: Journal Article

Zesiewicz, TA, KL Sullivan, RA Hauser, and J Sanchez-Ramos. 2006. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Chorea in Huntington’s Disease.”. Mov Disord.

The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.

Publication: Journal Article

Zesiewicz, TA, L Wecker, KL Sullivan, LR Merlin, and RA Hauser. 2006. “The Controversy Concerning Plasma Homocysteine in Parkinson Disease Patients Treated With Levodopa Alone or With Entacapone: Effects of Vitamin Status.”. Clinical Neuropharmacology.

Bachelor of Biomedicine and specialist in Clinical Analysis by University of Minas Gerais in Brazil, 2017. Master of Science in Morphofunctional Biology by the University of Sao Paulo in Brazil, 2020. PhD student at Life Sistems Program of the Department of Anatomy of the Institute of Biomedical...

Dr. DaZhi Wang

Person: Professor, USF Health Heart Institute, Director, Center for Regenerative Medicine, Endowed Chair of Cardiovascular Medicine

I am a developmental and molecular biologist with a longstanding interest in the molecular mechanisms that regulate mammalian development, cell fate determination, and human disease. In particular, my research group studies transcriptional regulation and miRNA-mediated post-transcriptional...

Katia Maria Gomes Andrade

Person: Postdoctoral Research Scholar

My name is Katia Andrade, and I am from Brazil. I am a post-doc in Dr. Zhigao Wang’s lab at the USF Heart institute (2023 - present). I have a Ph.D. in Systems Biology from the Institute of Biomedical Sciences at the University of São Paulo (ICB-USP, 2020 - Brazil), with a Sandwich Ph.D. at Harvard...

Search

Search results

Adenosine A2A receptor antagonists for Parkinson’s disease: rationale, therapeutic potential and clinical experience. Drugs Aging. 2005;22:471-482.

Levetiracetam for the treatment of essential tremor. Movement Disorders 2005; 20:640.

Maha Ahmed joins the lab!

Dr. Zietara awarded a T32 grant

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington’s disease.

The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.

Nihan Semerci Gunay

Tabatha de Oliveira Silva

Dr. DaZhi Wang

Katia Maria Gomes Andrade